China grants first COVID-19 vaccine patent to CanSino Biologics' 'experimental vaccine'

Shortly after Chinese Army received approval for us of a COVID-19 experimental vaccine jointly developed by military's research unit and CanSi Biologics, Chinese media on Tuesday reported that country h granted its first COVID-19 vaccine patent to it. " evirus vector vaccine candidate was found to be safe and able to trigger an immune response in first and second sts of clinical trials," reported state-sponsored media China Daily on Tuesday.

Re: CanSi's Vaccine For COVID-19 Gets d For Military Use In China

Re: COVID-19 Vaccine: Govt Panel Meets Representatives Of Leing Domestic Manufacturers

According to Chinese media, vaccine is yet to complete third and largest phase of trials before gaining market approval, however, animal studies have demonstrated vaccine's ability to reduce viral amounts in lungs reby inducing immunity. As per  patent document published on website of National Intellectual Property ministration, application for newly issued patent was submitted on March 18, and was approved on Aug 11, China Daily reported.

Back on June 29, CanSi Biologics stated that clinical trials of vaccine proved to be safe and apparently, even efficient. According to an international media ncy, 5-nCoV is one of eight vaccine candidates that are currently being developed by China-based firms while global deaths have surpassed 7 lakh. It was also first vaccine to enter first-st clinical trials in China back in March at onset of global outbreak of Coronavirus. It's second-st trials began worldwide on April 12.

Along with Chinese military, 5-nCoV has also been approved by Canian government for human testing in country.  vaccine candidate has been jointly developed by CanSi Biologics and Beijing Institute of Biotechlogy in Acemy of Military Medical Sciences.  phase-three clinical trials will be conducted overseas and planning is currently in pipeline, according to Chinese reports, however,  location is yet to be ascertained. 

Re: UK Urges Elderly, Black And Asian Mirity Groups To Sign Up For COVID-19 Vaccine Trial

Re: Russia To Conduct Clinical Trials Of Its Controversial Coronavirus Vaccine In Saudi Arabia